Canadian Journal of Cardiology

Papers
(The H4-Index of Canadian Journal of Cardiology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here?622
USE OF ARTS-BASED METHODS IN RESEARCH DESIGN TO ENHANCE PATIENT ENGAGEMENT369
LOW-DOSE EMPAGLIFLOZIN AS ADJUNCT TO HYBRID CLOSED-LOOP INSULIN THERAPY IN SUB-OPTIMALLY CONTROLLED ADULTS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER CONTROLLED TRIAL84
Open Access Budget Impact Assessment Tools: A Welcome Step in Supporting Evidence-Informed Policy Decisions81
A MISSED PULMONARY ARTERY SARCOMA REQUIRING RADICAL EXCISION AND PNEUMONECTOMY: SURGICAL TECHNIQUE73
ACUTE PACING THRESHOLD ELEVATION DURING SIMULTANEOUS L0EADLESS PACEMAKER IMPLANTATION AND ATRIOVENTRICULAR NODE ABLATION72
DRIVING RESTRICTION AND EARLY ARRHYTHMIAS IN PATIENTS RECEIVING A SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (DREAM SICD STUDY)60
MUSCLE SYMPATHETIC EXCITATORY RESPONSES TO DYNAMIC ONE-LEG CYCLING EXERCISE ARE AUGMENTED IN HEART FAILURE WITH PRESERVED EJECTION FRACTION55
PENTRAXIN-3 AS A NOVEL CARDIOTOXIC BIOMARKER FOR BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINES AND THE IMPACT OF PHYSICAL ACTIVITY: AN INTERIM REPORT FROM THE EXACT 2.0 TRIAL52
EVALUATION OF REAL-WORLD MANAGEMENT STRATEGIES ADOPTED IN PATIENTS WITH ATRIAL FIBRILLATION ON ANTICOAGULANTS FOLLOWING AN EPISODE OF CLINICALLY SIGNIFICANT BLEEDING51
GENETIC TESTING IN MONOGENIC EARLY-ONSET ATRIAL FIBRILLATION49
EXPLORING THE GENETIC BASIS OF DYSPNEA IN INDIVIDUALS TREATED WITH TICAGRELOR: RESULTS FROM THREE CLINICAL TRIALS49
TRIAGING REFERRALS TO ECONSULTS (TREC): PROOF OF CONCEPT46
ISOLATING THE EFFECT OF A SYSTEMIC RIGHT VENTRICLE WITH BI-VENTRICULAR CIRCULATION ON CARDIORESPIRATORY FITNESS45
SUICIDAL IDEATION, SUICIDE ATTEMPTS, AND SUICIDE DEATHS IN ADOLESCENTS AND YOUNG ADULTS WITH TYPE 1 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS44
EUGLYCEMIC KETOACIDOSIS IN TYPE 1 DIABETES ON AN AUTOMATED INSULIN DELIVERY SYSTEM IMMEDIATELY AFTER BARIATRIC SURGERY: A CASE SERIES41
EDGE-TO-EDGE TECHNIQUE WITH PARTIAL BAND FOR MITRAL VALVE REPAIR COMPARED TO MITRAL REPLACEMENT FOR ISCHEMIC MITRAL REGURGITATION40
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA39
Testosterone Treatment Impairs Cardiac Function and Fatty Acid Metabolism in a Rodent Model of Polycystic Ovary Syndrome38
COMMUNITY-TO-INSTITUTION ATHLETIC CARDIOVASCULAR SCREENING: VALIDATION OF AN ELECTROCARDIOGRAM WORKFLOW MODEL37
SUPPORTIVE CARDIOLOGY: A QUALITY IMPROVEMENT PROJECT TO MEET THE GAPS IN LATE-STAGE HEART FAILURE CARE36
IS FLAXSEED EQUIVALENT AND/OR SYNERGISTIC WITH ACE INHIBITION IN THE TREATMENT OF CHEMOTHERAPY MEDIATED CARDIOTOXICITY?35
A PROPENSITY-MATCHED COHORT STUDY TO ASSESS THE EFFECTIVENESS OF A COMMUNITY HOSPITAL BASED HEART FUNCTION CLINIC35
SCREENING OF PATIENTS AT RISK FOR WILD TYPE ATTR-CM USING A COMPUTATIONAL MACHINE LEARNING ALGORITHM34
SIRT3 PREVENTS DOXORUBICIN INDUCED DILATED CARDIOMYOPATHY VIA REGULATION OF MITOCHONDRIAL PROTEIN ACETYLATION: INVESTIGATING METABOLIC DYSFUNCTION AS A RESULT OF ALTERATIONS TO CARDIAC LIPIDS34
RACIAL/ETHNIC DIFFERENCES IN CARDIOVASCULAR OUTCOMES IN A UNIVERSAL HEALTHCARE SYSTEM: INSIGHTS FROM THE CARTAGENE COHORT33
Linking Plasma LTBP-2 Levels and Clinical Outcomes in Patients With Dilated Cardiomyopathy33
CARDIOVASCULAR DISEASE MANAGEMENT IN PEOPLE EXPERIENCING HOMELESSNESS: A SCOPING REVIEW33
Coronary Access and PCI after Transcatheter Aortic Valve Replacement With Different Self-Expanding Platforms in Failed Surgical Valves32
Decoding Long Noncoding RNAs in Myocardial Infarction: A Step Closer to a "Magic Bullet"?32
Beta-Blockers, Digoxin, or Both Following an Incident Diagnosis of Atrial Fibrillation: A Prospective Cohort Study32
Rubidium-82 Positron Emission Tomography With Intravenous Ergonovine to Diagnose Vasospastic Angina31
0.049789905548096